<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Mississippi Business Journal &#187; product introduction</title>
	<atom:link href="http://msbusiness.com/blog/tag/product-introduction/feed/" rel="self" type="application/rss+xml" />
	<link>http://msbusiness.com</link>
	<description>Mississippi Business Journal</description>
	<lastBuildDate>Wed, 22 May 2013 12:34:20 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>FDA approves Cypress&#8217; new cold medicines</title>
		<link>http://msbusiness.com/blog/2011/06/14/fda-approves-cypress-new-cold-medicines/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=fda-approves-cypress-new-cold-medicines</link>
		<comments>http://msbusiness.com/blog/2011/06/14/fda-approves-cypress-new-cold-medicines/#comments</comments>
		<pubDate>Tue, 14 Jun 2011 17:21:48 +0000</pubDate>
		<dc:creator>For the MBJ</dc:creator>
				<category><![CDATA[HEALTH CARE - Market Sector]]></category>
		<category><![CDATA[MANUFACTURING/PRIVATE COMPANIES - Market Sector]]></category>
		<category><![CDATA[NEWS]]></category>
		<category><![CDATA[distribution]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[federal government]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[product introduction]]></category>
		<category><![CDATA[product roll-out]]></category>

		<guid isPermaLink="false">http://msbusiness.com/?p=42480</guid>
		<description><![CDATA[<p>MADISON — Cypress Pharmaceutical announced the Food and Drug Administration (FDA) has approved a new drug application (NDA) for Zutripro (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution (CIII) and Rezira (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution (CIII). Both products are indicated for the relief of cough and symptoms associated with the common [...]</p><p>The post <a href="http://msbusiness.com/blog/2011/06/14/fda-approves-cypress-new-cold-medicines/">FDA approves Cypress&#8217; new cold medicines</a> appeared first on <a href="http://msbusiness.com">Mississippi Business Journal</a>.</p>]]></description>
		<wfw:commentRss>http://msbusiness.com/blog/2011/06/14/fda-approves-cypress-new-cold-medicines/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>
